Refresh

Fischer Medical Ventures Ltd.

Price on BSE   22 Apr,10:30 LIVE
38.00
-0.96
(-2.46%)

© 2026 Rediff.com
  • Volume :
  • 23,033.00
  • Prev Close :
  • 38.96
  • Day's H/L (Rs.) :
  • 38.40 - 37.70
  • 52wk H/L (Rs.) :
  • 124.20 - 32.09
  • Mkt Cap (Rs. Cr) :
  • 2,464.30
Price on NSE   22 Apr,11:38 LIVE
37.62
-1.38
(-3.54%)

© 2026 Rediff.com
  • Volume :
  • 1,001,736.00
  • Prev Close :
  • 39.00
  • Day's H/L (Rs.) :
  • 38.44 - 37.40
  • 52wk H/L (Rs.) :
  • 124.70 - 32.01
  • Mkt Cap (Rs. Cr) :
  • 0.00
Report Card - Fischer Medical Ventures Ltd.
PE Ratios
3,142.88
EPS (Rs.)
0.01
Sales (Rs. Cr)
1.32
Face Value (Rs.)
1
Net Profit Margin(%)
12.70
Last Bonus
-
Last Dividend(%)
.5
Return on Average Equity
0.21

News for Chemicals

India Real Estate: Capital Inflows Rise 72% to $5.1 Billion
Indian real estate sees record $5.1 billion capital inflow in Jan-Mar, a 72% rise. Developers & REITs drive growth despite global uncertainty.
Apr 22, 2026 11:03
Ajanta Pharma Gets USFDA Form 483 with 5 Observations
USFDA issues Form 483 with five observations to Ajanta Pharma's Paithan facility in Maharashtra after inspection. Company to respond soon.
Apr 22, 2026 10:59
Lupin Launches Anti-Diabetic Tablets in US
Lupin launches generic dapagliflozin and metformin hydrochloride extended-release tablets in the US after USFDA approval.
Apr 22, 2026 10:51
HCLTech Shares Tank After Earnings
HCLTech shares fell nearly 10% after March quarter earnings. FY27 growth guidance is 1-4%. AI revenue crosses $620M.
Apr 22, 2026 10:48
RBI Monitors FDI Outflows, Exchange Rates
RBI Governor Sanjay Malhotra closely monitors short-term fluctuations like FDI outflows and exchange rate movements. India's strong macroeconomic fundamentals highlighted.
Apr 22, 2026 10:48

More News »

Top News

India Real Estate: Capital Inflows Rise 72% to $5.1 Billion
Indian real estate sees record $5.1 billion capital inflow in Jan-Mar, a 72% rise. Developers & REITs drive growth despite global uncertainty.
Apr 22, 2026 11:03
Ajanta Pharma Gets USFDA Form 483 with 5 Observations
USFDA issues Form 483 with five observations to Ajanta Pharma's Paithan facility in Maharashtra after inspection. Company to respond soon.
Apr 22, 2026 10:59
Lupin Launches Anti-Diabetic Tablets in US
Lupin launches generic dapagliflozin and metformin hydrochloride extended-release tablets in the US after USFDA approval.
Apr 22, 2026 10:51
HCLTech Shares Tank After Earnings
HCLTech shares fell nearly 10% after March quarter earnings. FY27 growth guidance is 1-4%. AI revenue crosses $620M.
Apr 22, 2026 10:48
RBI Monitors FDI Outflows, Exchange Rates
RBI Governor Sanjay Malhotra closely monitors short-term fluctuations like FDI outflows and exchange rate movements. India's strong macroeconomic fundamentals highlighted.
Apr 22, 2026 10:48

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com